Unraveling anti-atherosclerosis mechanism of anthocyanins from Xinjiang wild cherry plum (Prunus divaricata Ledeb) via network pharmacology and molecular docking

Abstract

Atherosclerosis is a chronic vascular disease characterized by failure to resolve inflammation and forming plaque within the arterial wall. Atherosclerosis and its related cardiovascular diseases are the major causes of death worldwide. Our previous preliminary study showed that anthocyanin-rich extract (ACNE) from Xinjiang wild cherry plum (Prunus divaricata Ledeb) fruit peels exhibited anti-atherosclerotic effect. However, the potential mechanism of this health-beneficial effect remains unclear. Here, network pharmacology combined with molecular docking was used to tentatively address this issue. The ACNE mainly contains cyanidin, cyanidin 3-glucoside (Cy3Glu), Cyanidin 3-(6’’-acetylglucoside) (Cy3AcGlu), cyanidin 3-galactoside (Cy3Gal), cyanidin 3-xyloside (Cy3Xyl), and cyanidin 3-rutinoside (Cy3Rut). Seven key targets, EGFR, VEGFA, HSP90AA1, SRC, HIF1A, CXCR4 and IGF1R were identified from core protein-protein interaction (PPI) network. Anthocyanins interacting on key targets were initially demonstrated by molecular docking, particularly Cy3Rut and Cy3Xyl having highest affinity with most key targets. Biological function analysis suggested that key targets were involved in several biological processes, including positive regulation of cell migration, positive regulation of phosphorylation, inflammatory response, response to hypoxia, etc. The significantly enriched pathways, such as HIF-1 signaling pathway, calcium signaling pathway, macrophage stimulating protein MSP signaling network map, were closely related to atherosclerosis. Altogether, based on the comprehensive analysis and discussion, we revealed that TLR4/EGFR and IGF1R-CXCL12/CXCR4 pathways were at least partially implicated in the anti-atherosclerotic effects of anthocyanins through affecting inflammation, endothelial homeostasis, and foam cell formation. This study served as a theoretical basis for further validating the underlying anti-atherosclerotic mechanism of anthocyanins via in vitro and in vivo experiments.

Keywords

Biological Sciences / Biochemistry and Cell Biology

References

[1] AbeRJ, AbeJ-i, NguyenMTH, Olmsted-DavisEA, MamunA, BanerjeeP, CookeJP, FangL, PownallH, LeN-T. Free cholesterol bioavailability and atherosclerosis. Curr Atheroscler Rep, 2022, 24: 323-336.

[2] AkhtarS, HartmannP, KarshovskaE, RinderknechtFA, SubramanianP, GremseF, GrommesJ, JacobsM, KiesslingF, WeberC, SteffensS, SchoberA. Endothelial hypoxia-inducible factor-1α promotes atherosclerosis and monocyte recruitment by upregulating microRNA-19a. Hypertension, 2015, 66: 1220-1226.

[3] AnduezaA, KumarS, KimJ, KangD-W, MummeHL, PerezJI, Villa-RoelN, JoH. Endothelial reprogramming by disturbed flow revealed by single-cell RNA and chromatin accessibility study. Cell Rep, 2020, 33: 108491.

[4] Bayazid AB, Lim BO (2024) Therapeutic effects of plant anthocyanin against Alzheimer’s disease and modulate gut health, short-chain fatty acids. Nutrients 16:1554. https://doi.org/10.3390/nu16111554

[5] BeletkaiaE, FenzSF, PompW, Snaar-JagalskaBE, HogendoornPWC, SchmidtT. CXCR4 signaling is controlled by immobilization at the plasma membrane. Biochimica et biophysica acta (BBA). Mol Cell Res, 2016, 1863: 607-616.

[6] BergheanuSC, BoddeMC, JukemaJW. Pathophysiology and treatment of atherosclerosis: current view and future perspective on lipoprotein modification treatment. Neth Heart J, 2017, 25: 231-242.

[7] BjörkegrenJLM, LusisAJ. Atherosclerosis: recent developments. Cell, 2022, 185: 1630-1645.

[8] ChenK, KortesniemiMK, LinderborgKM, YangB. Anthocyanins as promising molecules affecting energy homeostasis, inflammation, and gut microbiota in type 2 diabetes with special reference to impact of acylation. J Agric Food Chem, 2023, 71: 1002-1017.

[9] Dabravolski SA, Khotina VA, Omelchenko AV, Kalmykov VA, Orekhov AN (2022) The role of the VEGF family in atherosclerosis development and its potential as treatment targets. Int J Mol Sci 23:931. https://doi.org/10.3390/ijms23020931

[10] Danielewski M, Gomułkiewicz A, Kucharska AZ, Matuszewska A, Nowak B, Piórecki N, Trocha M, Szandruk-Bender M, Jawień P, Szeląg A, Dzięgiel P, Sozański T (2023) Cornelian Cherry (Cornus Mas L.) iridoid and anthocyanin-rich extract reduces various oxidation, inflammation, and adhesion markers in a cholesterol-rich diet rabbit model. Int J Mol Sci 24:3890. https://doi.org/10.3390/ijms24043890

[11] de MirandaMC, RodriguesMA, de Angelis CamposAC, FariaJ, Kunrath-LimaM, MigneryGA, SchechtmanD, GoesAM, NathansonMH, GomesDA. Epidermal growth factor (EGF) triggers nuclear calcium signaling through the intranuclear phospholipase Cδ-4 (PLCδ4). J Biol Chem, 2019, 294: 16650-16662.

[12] Dias KA, Oliveira LA, Pereira SMS, Abrantes LCS, Vicente L, Gonçalves RV, Della Lucia CM (2025) Anti-inflammatory and antioxidant effects of anthocyanins in nonalcoholic fatty liver disease (NAFLD): a systematic review of in vivo studies. Crit Rev Food Sci Nutr 1–18. https://doi.org/10.1080/10408398.2025.2472882

[13] Ding X, Meng C, Dong H, Zhang S, Zhou H, Tan W, Huang L, He A, Li J, Huang J, Li W, Zou F, Zou M (2022) Extracellular Hsp90α, which participates in vascular inflammation, is a novel serum predictor of atherosclerosis in type 2 diabetes. BMJ Open Diabetes Res Care 10:e002579. https://doi.org/10.1136/bmjdrc-2021-002579

[14] DöringY, NoelsH, van der VorstEPC, NeideckC, EgeaV, DrechslerM, MandlM, PawigL, JansenY, SchröderK, BidzhekovK, MegensRTA, TheelenW, KlinkhammerBM, BoorP, SchurgersL, van GorpR, RiesC, KustersPJH, van der WalA, HackengTM, GäbelG, BrandesRP, SoehnleinO, LutgensE, VestweberD, TeupserD, HoldtLM, RaderDJ, SaleheenD, WeberC. Vascular CXCR4 limits atherosclerosis by maintaining arterial integrity: evidence from mouse and human studies. Circulation, 2017, 136: 388-403.

[15] DöringY, JansenY, CimenI, AslaniM, GencerS, PetersLJF, DucheneJ, WeberC, van der VorstEPC. B-cell-specific CXCR4 protects against atherosclerosis development and increases plasma IgM levels. Circul Res, 2020, 126: 787-788.

[16] DubourgV, SchwerdtG, SchreierB, KopfM, MildenbergerS, BenndorfRA, GekleM. EGFR activation differentially affects the inflammatory profiles of female human aortic and coronary artery endothelial cells. Sci Rep, 2023, 13: 22827.

[17] EngelenSE, RobinsonAJB, ZurkeYX, MonacoC. Therapeutic strategies targeting inflammation and immunity in atherosclerosis: how to proceed? Nature reviews. Cardiology, 2022, 19: 522-542.

[18] FaehlingM, KrollJ, FöhrKJ, FellbrichG, MayrU, TrischlerG, WaltenbergerJ. Essential role of calcium in vascular endothelial growth factor A-induced signaling: mechanism of the antiangiogenic effect of Carboxyamidotriazole. Faseb J, 2002, 16: 1805-1807.

[19] FangF, FengT, LiJ, ZhangH, WangQ, ChenY, WangG, ShenY, LiuX. Cathepsin K contributed to disturbed flow-induced atherosclerosis is dependent on integrin-actin cytoskeleton-NF-κB pathway. Genes Dis, 2023, 10: 583-595.

[20] Franco-San Sebastián D, Alaniz-Monreal S, Rabadán-Chávez G, Vázquez-Manjarrez N, Hernández-Ortega M, Gutiérrez-Salmeán G (2023) Anthocyanins: potential therapeutic approaches towards obesity and diabetes mellitus type 2. Molecules 28:1237. https://doi.org/10.3390/molecules28031237

[21] HeY, HuY, JiangX, ChenT, MaY, WuS, SunJ, JiaoR, LiX, DengL, BaiW. Cyanidin-3-O-glucoside inhibits the UVB-induced ROS/COX-2 pathway in HaCaT cells. J Photochem Photobiol B, 2017, 177: 24-31.

[22] JiaY, WuC, KimY-S, YangSO, KimY, KimJ-S, JeongM-Y, LeeJH, KimB, LeeS, OhH-S, KimJ, SoM-Y, YoonYE, ThachTT, ParkTH, LeeS-J. A dietary anthocyanin cyanidin-3-O-glucoside binds to PPARs to regulate glucose metabolism and insulin sensitivity in mice. Commun Biology, 2020, 3: 514.

[23] JungH, KwakH-K, HwangKT. Antioxidant and antiinflammatory activities of cyanidin-3-glucoside and cyanidin-3-rutinoside in hydrogen peroxide and lipopolysaccharide-treated RAW264.7 cells. Food Sci Biotechnol, 2014, 23: 2053-2062.

[24] KalampogiasA, SiasosG, OikonomouE, TsalamandrisS, MourouzisK, TsigkouV, VavuranakisM, ZografosT, DeftereosS, StefanadisC, TousoulisD. Basic mechanisms in atherosclerosis: the role of calcium. Med Chem, 2016, 12: 103-113.

[25] KongP, CuiZY, HuangXF, ZhangDD, GuoRJ, HanM. Inflammation and atherosclerosis: signaling pathways and therapeutic intervention. Signal Transduct Target Therapy, 2022, 7: 131.

[26] Kozłowska A, Nitsch-Osuch A (2024) Anthocyanins and type 2 diabetes: an update of human study and clinical trial. Nutrients 16:1674. https://doi.org/10.3390/nu16111674

[27] LazaroI, OguizaA, RecioC, Lopez-SanzL, BernalS, EgidoJ, Gomez-GuerreroC. Interplay between HSP90 and Nrf2 pathways in diabetes-associated atherosclerosis. Clin Investig Arterioscler, 2017, 29: 51-59.

[28] LiX, ShiZ, ZhuY, ShenT, WangH, ShuiG, LoorJJ, FangZ, ChenM, WangX, PengZ, SongY, WangZ, DuX, LiuG. Cyanidin-3-O-glucoside improves non-alcoholic fatty liver disease by promoting PINK1-mediated mitophagy in mice. Br J Pharmacol, 2020, 177: 3591-3607.

[29] LiH, GaoL, ShaoH, LiB, ZhangC, ShengH, ZhuL. Elucidation of active ingredients and mechanism of action of Hawthorn in the prevention and treatment of atherosclerosis. J Food Biochem, 2022, 46: e14457.

[30] LiL, LiuS, TanJ, WeiL, WuD, GaoS, WengY, ChenJ. Recent advance in treatment of atherosclerosis: key targets and plaque-positioned delivery strategies. J Tissue Eng, 2022, 13: 20417314221088509.

[31] LiY, CaoGY, JingWZ, LiuJ, LiuM. Global trends and regional differences in incidence and mortality of cardiovascular disease, 1990–2019: findings from 2019 global burden of disease study. Eur J Prev Cardiol, 2023, 30: 276-286.

[32] LiangD, YixuanD, ChangL, JingjingS, SihaiZ, JieD. Mechanism of L. in the treatment of acute myocardial infarction: network pharmacology, molecular Docking and in vivo validation. Mol Diversity, 2023.

[33] LibbyP. The changing landscape of atherosclerosis. Nature, 2021, 592: 524-533.

[34] LiuX, LiuW, GeY, LiuT, AnX. Determination of polyphenol content and antioxidant activity in Peel. J Yili Normal University(Natural Sci Edition), 2019, 13: 48-53

[35] LiuM, LiS, GuanM, BaiS, BaiW, JiangX. Leptin pathway is a crucial target for anthocyanins to protect against metabolic syndrome. Crit Rev Food Sci Nutr, 2025, 65: 2046-2061.

[36] LuoY, FangJ-L, YuanK, JinS-H, GuoY. Ameliorative effect of purified anthocyanin from Lycium ruthenicum on atherosclerosis in rats through synergistic modulation of the gut microbiota and NF-κB/SREBP-2 pathways. J Funct Foods, 2019, 59: 223-233.

[37] MohammadiN, FarrellM, O’SullivanL, LanganA, FranchinM, AzevedoL, GranatoD. Effectiveness of anthocyanin-containing foods and nutraceuticals in mitigating oxidative stress, inflammation, and cardiovascular health-related biomarkers: a systematic review of animal and human interventions. Food Funct, 2024, 15: 3274-3299.

[38] Nava-Ochoa A, Mertens-Talcott SU, Talcott ST, Noratto GD (2025) Dark sweet Cherry (Prunus avium L.) juice phenolics rich in anthocyanins exhibit potential to inhibit drug resistance mechanisms in 4T1 breast cancer cells via the drug metabolism pathway. Curr Issues Mol Biol 47:213. https://doi.org/10.3390/cimb47030213

[39] OrtizMA, MikhailovaT, LiX, PorterBA, BahA, KotulaL. Src family kinases, adaptor proteins and the actin cytoskeleton in epithelial-to-mesenchymal transition. Cell Communication Signaling: CCS, 2021, 19: 67.

[40] Papavassiliou KA, Sofianidi AA, Papavassiliou AG (2024) Anthocyanins in non-small cell lung cancer (NSCLC) treatment and prevention. Nutrients 16:1458. https://doi.org/10.3390/nu16101458

[41] PlankMJ, WallDJ, DavidT. Atherosclerosis and calcium signalling in endothelial cells. Prog Biophys Mol Biol, 2006, 91: 287-313.

[42] Qi S, Yi G, Yu K, Feng C, Deng S (2022) The role of HSP90 inhibitors in the treatment of cardiovascular diseases. Cells 11:3444. https://doi.org/10.3390/cells11213444

[43] RidkerPM, BhattDL, PradhanAD, GlynnRJ, MacFadyenJG, NissenSE. Inflammation and cholesterol as predictors of cardiovascular events among patients receiving Statin therapy: a collaborative analysis of three randomised trials. Lancet, 2023, 401: 1293-1301.

[44] ShenJ, ZhangP, ZhangX, YaoJ, ChangJM. Extraction process and composition identification of anthocyanins from Xinjiang wild fruit Peel. Pak J Pharm Sci, 2021, 34: 2409-2415

[45] ShenJ, LiX, ZhangX, LiZ, AbulaitiG, LiuY, YaoJ, ZhangP. Effects of Xinjiang wild Cherry Plum ( Ledeb) anthocyanin-rich extract on the plasma metabolome of atherosclerotic apoE-deficient mice fed a high-fat diet. Front Nutr, 2022, 9: 923699.

[46] SmanalievaJ, IskakovaJ, OskonbaevaZ, WichernF, DarrD. Determination of physicochemical parameters, phenolic content, and antioxidant capacity of wild Cherry Plum ( Ledeb.) from the walnut-fruit forests of Kyrgyzstan. Eur Food Res Technol, 2019, 245: 2293-2301.

[47] SongYJ, MaY, MengT, ZhuangT, RuanCC, LiY, ZhangGN. The characteristics of macrophage heterogeneity in atherosclerotic aortas. J Cardiovasc Transl Res, 2024, 17: 153-166.

[48] StroopeC, NettersheimFS, CoonB, FinneyAC, SchwartzMA, LeyK, RomO, YurdagulAJr. Dysregulated cellular metabolism in atherosclerosis: mediators and therapeutic opportunities. Nat Metabolism, 2024, 6: 617-638.

[49] SunT, QuanW, PengS, YangD, LiuJ, HeC, ChenY, HuB, TuoQ. Network pharmacology-based strategy combined with molecular Docking and in vitro validation study to explore the underlying mechanism of Huo Luo Xiao Ling Dan in treating atherosclerosis. Drug Des Devel Ther, 2022, 16: 1621-1645.

[50] Szekeres R, Priksz D, Kiss R, Romanescu DD, Bombicz M, Varga B, Gesztelyi R, Szilagyi A, Takacs B, Tarjanyi V, Pelles-Tasko B, Forgacs I, Remenyik J, Szilvassy Z, Juhasz B (2023) Therapeutic aspects of Prunus cerasus extract in a rabbit model of atherosclerosis-associated diastolic dysfunction. Int J Mol Sci 24:13253. https://doi.org/10.3390/ijms241713253

[51] ThummayotS, TocharusC, JumnongprakhonP, SuksamrarnA, TocharusJ. Cyanidin attenuates Aβ(25–35)-induced neuroinflammation by suppressing NF-κB activity downstream of TLR4/NOX4 in human neuroblastoma cells. Acta Pharmacol Sin, 2018, 39: 1439-1452.

[52] VermaS, MazerCD, ConnellyKA. Inflammation and cholesterol at the crossroads of vascular risk. Cell Metabol, 2023, 35: 1095-1098.

[53] WangL, XuZ, LiaoK, ZhaoY, ZhouL. Study on ecology-biology of wild Cherry Plum in Xinjiang I. The analysis on ecology factors with characters of botanic, phynology, distribution. Xinjiang Agric Sci, 2006, 43: 87-95.

[54] Wang Y, Chen X, Zhang Y, Chen X (2012a) Antioxidant activities and major anthocyanins of Myrobalan plum (Prunus cerasifera Ehrh). J Food Sci 77:C388-393. https://doi.org/10.1111/j.1750-3841.2012.02624.x

[55] WangY, ZhangY, WangX, LiuY, XiaM. Cyanidin-3-O-β-glucoside induces oxysterol efflux from endothelial cells: role of liver X receptor alpha. Atherosclerosis, 2012, 223: 299-305.

[56] WangL, HuangZ, HuangW, ChenX, ShanP, ZhongP, KhanZ, WangJ, FangQ, LiangG, WangY. Inhibition of epidermal growth factor receptor attenuates atherosclerosis via decreasing inflammation and oxidative stress. Sci Rep, 2017, 8: 45917.

[57] WangP, ZengG, YanY, ZhangSY, DongY, ZhangY, ZhangX, LiuH, ZhangZ, JiangC, PangY. Disruption of adipocyte HIF-1α improves atherosclerosis through the Inhibition of ceramide generation. Acta Pharm Sinica B, 2022, 12: 1899-1912.

[58] WolfD, LeyK. Immunity and inflammation in atherosclerosis. Circul Res, 2019, 124: 315-327.

[59] XinM, XuA, TianJ, WangL, HeY, JiangH, YangB, LiB, SunY. Anthocyanins as natural bioactives with anti-hypertensive and atherosclerotic potential: health benefits and recent advances. Phytomedicine, 2024, 132: 155889.

[60] Yan F, Ding H, Sun Z, Liu J, Li J, Zhou D, Zhang W (2023) Glycoside combinations of Buyang Huanwu decoction ameliorate atherosclerosis via STAT3, HIF-1, and VEGF. Naunyn-Schmiedeberg’s archives of pharmacology 396:1187–1203. https://doi.org/10.1007/s00210-023-02389-6

[61] YangS, MiL, WuJ, LiaoX, XuZ. Strategy for anthocyanins production: from efficient green extraction to novel microbial biosynthesis. Crit Rev Food Sci Nutr, 2023, 63: 9409-9424.

[62] YaoY, ZhangX, XuY, ZhaoY, SongF, TianZ, ZhaoM, LiangY, LingW, MaoY-H, YangY. Cyanidin-3-O-β-glucoside attenuates platelet chemokines and their receptors in atherosclerotic inflammation of ApoE^–/– mice. J Agric Food Chem, 2022, 70: 8254-8263.

[63] Zaa CA, Marcelo Á, An J, Medina-Franco Z, J. L. and, Velasco-Velázquez MA (2023) Anthocyanins: molecular aspects on their neuroprotective activity. Biomolecules 13:1598. https://doi.org/10.3390/biom13111598

[64] ZeboudjL, GiraudA, GuyonnetL, ZhangY, LauransL, EspositoB, VilarJ, ChipontA, Papac-MilicevicN, BinderCJ, TedguiA, MallatZ, TharauxPL, Ait-OufellaH. Selective EGFR (epidermal growth factor receptor) deletion in myeloid cells limits atherosclerosis-brief report. Arterioscler Thromb Vasc Biol, 2018, 38: 114-119.

[65] ZeboudjL, MaîtreM, GuyonnetL, LauransL, JoffreJ, LemarieJ, BourcierS, Nour-EldineW, GuérinC, FriardJ, WakkachA, FabreE, TedguiA, MallatZ, TharauxPL, Ait-OufellaH. Selective EGF-receptor Inhibition in CD4 T cells induces anergy and limits atherosclerosis. J Am Coll Cardiol, 2018, 71: 160-172.

[66] ZhaiY, YangJ, ZhangJ, YangJ, LiQ, ZhengT. Src-family protein tyrosine kinases: A promising target for treating cardiovascular diseases. Int J Med Sci, 2021, 18: 1216-1224.

[67] Zhang P, Zhu H (2023) Anthocyanins in plant food: current status, genetic modification, and future perspectives. Molecules 28:866. https://doi.org/10.3390/molecules28020866

[68] ZhaoY, LiY, LiuY, YangYF. Genetic diversity of wild ehrhart (wild Cherry plum) in China revealed by simple-sequence repeat markers. Genet Mol Research: GMR, 2015, 14: 8407-8413.

[69] ZhaoS, TangX, MiaoZ, ChenY, CaoJ, SongT, YouD, ZhongY, LinZ, WangD, ShiZ, TangX, WangD, ChenS, WangL, GuA, ChenF, XieL, HuangZ, WangH, JiY. Hsp90 S-nitrosylation at Cys521, as a conformational switch, modulates cycling of Hsp90-AHA1-CDC37 chaperone machine to aggravate atherosclerosis. Redox Biol, 2022, 52: 102290.

[70] ZhaoW, OuyangC, ZhangL, WangJ, ZhangJ, ZhangY, HuangC, XiaoQ, JiangB, LinF, ZhangC, ZhuM, XieC, HuangX, ZhangB, ZhaoW, HeJ, ChenS, LiuX, LinD, LiQ, WangZ. The proto-oncogene tyrosine kinase c-SRC facilitates glioblastoma progression by remodeling fatty acid synthesis. Nat Commun, 2024, 15: 7455.

Funding

National Natural Science Foundation of China-Xinjiang Joint Fund(82360827)

Hunan Province College Students Innovation and Entrepreneurship Training Program(Hunan Province College Students Innovation and Entrepreneurship Training Program)

RIGHTS & PERMISSIONS

The Author(s)